Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Jozefow

7 clinical trials in Jozefow, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Jozefow at a glance
7
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

7 trials in Jozefow

Open in trial search

Study on the Safety and Effectiveness of GSK5733584 with Dostarlimab and Carboplatin for Patients with Advanced Gynecological Tumors

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Glaxosmithkline Research & Development Limited

Safety and Efficacy of BMS-986528 with Tocilizumab in Patients with Refractory Rheumatoid Arthritis: A Phase 1/2a Open‑Label Study

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Tocilizumab
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Dyslipidaemia

Recruiting

Comparison of Obicetrapib and Bempedoic Acid in Patients with Dyslipidemia at High to Very High Cardiovascular Risk

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bempedoic Acid

Study of ISIS 678354 for Patients with Severe High Triglycerides

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:ISIS 678354 sodium salt
  • Sponsor:Ionis Pharmaceuticals Inc.

Dyslipidaemia

Not recruiting

Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Evolocumab
  • Sponsor:Amgen Inc.

Hypertriglyceridaemia

Not recruiting

Study of ISIS 678354 for Patients with Severe Hypertriglyceridemia

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:ISIS 678354 sodium salt
  • Sponsor:Ionis Pharmaceuticals Inc.

Gastric cancer

Not recruiting

Study of Bemarituzumab and Chemotherapy for Patients with Advanced Stomach or Gastroesophageal Cancer with FGFR2b Overexpression

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bemarituzumab
  • Sponsor:Amgen Inc.

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Jozefow

What the registry says about research in the country

01 Oncology Research

Innovative research focusing on advanced solid tumors, exploring combination therapies with novel compounds for enhanced treatment outcomes.

  • Gynecological Tumors
  • Advanced Solid Tumors
  • Combination Therapy Approaches

Studies evaluate safety profiles and therapeutic effectiveness of new treatment combinations.

02 Multi-Cancer Studies

Comprehensive research investigating targeted therapies across multiple cancer types, including innovative basket trial designs.

  • Cervical Cancer
  • Ovarian Cancer
  • Prostate Cancer
  • Endometrial Cancer
  • Urothelial Carcinoma

Focus on combination treatments with immunotherapy agents to improve patient outcomes.

03 Metabolic Disorders

Clinical investigations targeting severe hypertriglyceridemia, exploring new therapeutic approaches for lipid management.

  • Lipid Disorders
  • Novel Drug Development
  • Subcutaneous Treatments

Research aims to establish safety profiles and evaluate new treatment options for metabolic conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.